Growth pattern of tumor recurrence following bis-chloroethylnitrosourea (BCNU) wafer implantation in malignant glioma

Journal of Clinical Neuroscience

Volumn 20, Issue 3, 2013, Pages 429-434

  Dörner, Lutz ^a   Mustafa, Ahmad ^a   Rohr, Axel ^a   Mehdorn, H Maximilian ^a   Nabavi, Arya ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

BCNU wafer; Bis chloroethylnitrosourea; Gliadel; Growth pattern; Malignant glioma

Indexed keywords

CARMUSTINE; TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG IMPLANTATION; FEMALE; GLIOBLASTOMA; HUMAN; MALE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY;

ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CARMUSTINE; FEMALE; GLIOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL;

EID: 84875214791     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2012.01.060     Document Type: Article

References (39)

1. H. Brem, S. Piantadosi, and P.C. Burger Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas Lancet 345 1995 1008 1012
2. M. Westphal, D.C. Hilt, and E. Bortey A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafer (Gliadel wafers) in patients with primary malignant glioma Neuro-Oncology 5 2003 79 88
3. W. Dang, T. Daviau, and H. Brem Morphological characterization of polyanhydride biodegradable implant gliadel during in vitro and in vivo erosion using scanning electron microscopy Pharm Res 13 1996 683 691
4. L.K. Fung, M.G. Ewend, and A. Sills Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain Cancer Res 58 1998 672 684
5. A.B. Fleming, and W.M. Saltzman Pharmacokinetics of the carmustine implant Clin Pharmacokinet 41 2002 403 419
6. S.A. Grossman, C. Reinhard, and O.M. Colvin The intracerebral distribution of BCNU delivered by surgically implanted biodegradable polymers J Neurosurg 76 1992 640 647
7. L. Dörner, S. Ulmer, and A. Rohr Space-occupying cyst development in the resection cavity of malignant gliomas following Gliadel® implantation-incidence, therapy strategies, and outcome J Clin Neurosci 18 2011 347 351
8. J.P. Dyke, P.C. Sanelli, and H.U. Voss Monitoring the effects of the BCNU chemotherapy wafers (Gliadel®) in glioblastoma multiforme with proton magnetic resonance spectroscopic imaging at 3.0 Tesla J Neurooncol 82 2006 103 110
9. H.H. Engelhard Tumor bed cyst formation after BCNU wafer implantation: report of two cases Surg Neurol 53 2000 220 224
10. L.R. Kleinberg, J. Weingart, and P. Burger Clinical course and pathological findings after Gliadel® and radiotherapy for newly diagnosed malignant glioma: implications for patients' management Cancer Invest 22 2004 1 9
11. H.C. Lawson, P. Sampath, and E. Bohan Interstitial chemotherapy for malignant gliomas: the John Hopkins experience J Neurooncol 83 2006 61 70
12. M.J. McGirt, A.T. Villavicencio, and K.R. Bulsara Management of tumor bed cysts after chemotherapeutic wafer implantation J Neurosurg 96 2002 941 945
13. M. Sabel, and A. Giese Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience Curr Med Res Opin 24 2008 3239 3257
14. P.C. Burger, P.J. Dubois, and S.C. Schold (1983) Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme J Neurosurg 58 1983 159 169
15. E.L. Chang, S. Akyurek, and T. Avalos Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma Int J Radiat Oncol Biol Phys 68 2007 144 150
16. F.H. Hochberg, and A. Pruitt Assumptions in the radiotherapy of glioblastoma Neurology 30 1980 907 911
17. U. Oppitz, D. Maessen, and H. Zunterer 3D-recurrence-patterns of glioblastomas after CT-planned postoperative irradiation Radiother Oncol 53 1999 53 57
18. A. Giese, T. Kucinski, and U. Knopp Pattern of recurrence following local chemotherapy with biodegradable carmustine (BCNU) implants in patients with glioblastoma J Neurooncol 66 2004 351 360
19. A. Balossier, L. Dörner, and E. Emery Incorporating BCNU wafers into malignant glioma treatment: European case studies Clin Drug Investig 30 2010 195 204
20. LaRocca RV, Hodes J, Villanueva WG et al. (2006) A phase II study of radiation with concomitant and then sequential temozolomide (TMZ) in patients with newly diagnosed supratentorial high-grade malignant glioma who have undergone surgery with carmustine (BCNU) wafer insertion (abstract TA-28). J Clin Oncol 2005. ASCO Annual Meeting Proceedings. 2005; 23 (June 1 Suppl.): 1547.
21. R.V. LaRocca, and H.M. Mehdorn Localized BCNU chemotherapy and the multimodal management of malignant glioma Curr Med Res Opin 25 2009 149 160
22. M.J. McGirt, and H. Brem Carmustine wafers (Gliadel) plus concomitant temozolomide therapy after resection of malignant astrocytoma: growing evidence for safety and efficacy Ann Surg Oncol 17 2010 1729 1731
23. P. Metellus, B. Coulibaly, and I. Nanni Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort Cancer 115 2009 4783 4794
24. R. Stupp, W.P. Mason, and M.J. van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996
25. S. Dalĺoglio, A. D́Amico, and F. Pioli Dose intensified temozolomide after concurrent chemotherapy in operated high-grade gliomas J Neurooncol 90 2008 315 319
26. M.C. Chamberlain Radiographic pattern of recurrence in glioblastoma J Neurooncol 101 2011 319 323
27. A. Narayana, S.D. Kunnakkat, and P. Medabalmi Change in pattern of relapse after antiangiogenic therapy in high-grade glioma Int J Radiation Oncology Biol Phys 82 2012 77 82
28. O. Keunen, M. Johansson, and A. Oudin Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma Proc Natl Acad Sci USA 108 2011 3749 3754
29. M.T. Milano, P. Okunieff, and R.S. Donatello Patterns of recurrence after temozolomide -based chemoradiation for glioblastoma Int J Radiation Oncology Biol Phys 78 2010 1147 1155
30. C.-H. Wang, J. Li, and C.S. Teo The delivery of BCNU to brain tumors J Control Release 61 1999 21 41
31. S.J. Vaidya, D. Hargrave, and F. Saran Pattern of recurrence in pediatric glioma: an institutional experience J Neurooncol 83 2007 279 284
32. D.Y. Arifin, K.Y.T. Lee, and C.-H. Wang Role of convection flow in carmustine delivery to a brain tumor Pharmaceut Res 26 2009 2289 2302
33. M. Hartmann, O. Jansen, and T. Egelhof Effect of brain edema on the recurrence pattern of malignant gliomas Radiologe 38 1998 948 953
34. F. Earnest 4th, P.J. Kelly, and B.W. Scheithauer Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy Radiology 166 1988 823 827
35. W. Wick, R. Stupp, and A.C. Beule A novel tool to analyze MRI recurrence pattern in glioblastoma Neuro Oncol 10 2008 1019 1024
36. M. Watanabe, R. Tanaka, and N. Takeda Magnetic resonance imaging and histopathology of cerebral gliomas Neuroradiology 34 1992 463 469
37. A. Nabavi, H. Thurm, and B. Zountas Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase II study Neurosurgery 65 2009 1070 1076
38. W. Stummer, U. Pichlmeier, and T. Meinel Fluorescence guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicenter phase III trial Lancet Oncol 7 2006 392 401
39. A. Nabavi, L. Dörner, and A.M. Stark Intraoperative MRI with 1.5 Tesla in neurosurgery Neurosurg Clin N Am 20 2009 163 171